Neurotensin agonists: possible drugs for treatment of psychostimulant abuse.
about
Neurotensin receptor antagonist administered during cocaine withdrawal decreases locomotor sensitization and conditioned place preferenceElucidating the role of neurotensin in the pathophysiology and management of major mental disorders.Diverse roles of neurotensin agonists in the central nervous systemSystemic PD149163, a neurotensin receptor 1 agonist, decreases methamphetamine self-administration in DBA/2J mice without causing excessive sedationResponses of the rat basal ganglia neurotensin systems to low doses of methamphetamineRegulation of the Dopamine and Vesicular Monoamine Transporters: Pharmacological Targets and Implications for Disease.Effect of low doses of methamphetamine on rat limbic-related neurotensin systemsThe role of neurotensin in central nervous system pathophysiology: what is the evidence?The drive to eat: comparisons and distinctions between mechanisms of food reward and drug addictionML314: A Biased Neurotensin Receptor Ligand for Methamphetamine AbuseNeurotensin: A role in substance use disorder?The novel neurotensin analog NT69L blocks phencyclidine (PCP)-induced increases in locomotor activity and PCP-induced increases in monoamine and amino acids levels in the medial prefrontal cortex.Electron microscopic dual labeling of high-affinity neurotensin and dopamine D2 receptors in the rat nucleus accumbens shell.Methylphenidate alters basal ganglia neurotensin systems through dopaminergic mechanisms: a comparison with cocaine treatment.
P2860
Q24634249-C2173046-E88C-40D5-A692-15FC03B8FEDEQ30426586-0735DBE9-5119-448C-AFD2-118F04BA646BQ30456105-14254615-97E1-4D89-9B02-BE147B7A080BQ33884189-B3F40C07-CA40-4105-891F-95438149DE17Q33916740-BFDF93DA-C774-4D0E-886D-6FD95EAA0670Q34673305-058BD853-DF23-4811-A3EE-15944DD6110CQ35782992-01A702B4-AD82-4F79-B1A8-3B61AD3AB759Q36544566-7D51A038-6AE3-4C65-9183-D05B4DC94F38Q36604054-42FF37D4-EDD8-4F90-ABC9-708E064438E8Q37099122-D2CF4F5F-BF23-4ED5-B913-80174FBC163AQ38692971-37B1415B-E6E1-4886-A217-15466DDF5D47Q41879435-1D5D7659-E28B-4BA6-A59D-CC7A6B93E219Q44830950-1CFB317B-1046-4231-9ACC-C3B71439B2C5Q48286283-672EFB8C-5614-4E3A-A4B4-5D212E2D2891
P2860
Neurotensin agonists: possible drugs for treatment of psychostimulant abuse.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Neurotensin agonists: possible drugs for treatment of psychostimulant abuse.
@ast
Neurotensin agonists: possible drugs for treatment of psychostimulant abuse.
@en
type
label
Neurotensin agonists: possible drugs for treatment of psychostimulant abuse.
@ast
Neurotensin agonists: possible drugs for treatment of psychostimulant abuse.
@en
prefLabel
Neurotensin agonists: possible drugs for treatment of psychostimulant abuse.
@ast
Neurotensin agonists: possible drugs for treatment of psychostimulant abuse.
@en
P2093
P1433
P1476
Neurotensin agonists: possible drugs for treatment of psychostimulant abuse.
@en
P2093
Elliott Richelson
Mona Boules
Paul Fredrickson
P304
P356
10.1016/S0024-3205(03)00388-6
P407
P577
2003-06-01T00:00:00Z